✓
No active regulatory warnings
Sources: FDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
1 Identity
Glucosamine
Glucosamine sulfate / HCl
Generally SafeEvidence: ModerateOtherGlucosamine is an amino sugar naturally produced in the body as a precursor to glycosaminoglycans (GAGs) — the building blocks of cartilage proteoglycans [1]. It is one of the most widely consumed supplements worldwide, primarily for osteoarthritis (OA). The clinical evidence is controversial: the NIH-funded GAIT trial (n=1,583) found NO significant benefit of glucosamine HCl over placebo for knee OA pain, while European trials using the pharmaceutical-grade glucosamine sulfate (Rottapharm/Rotta formulation) showed both symptom relief and structural preservation [2]. The discrepancy may be due to differences in formulation, dose, and salt form [3].
2 Risk self-assessment
Not applicable — not an essential nutrient [1]
Select factors above to see your risk level
4 Dietary sources
Glucosamine is not found in normal foods in significant amounts. It is derived from chitin in shellfish shells (shrimp, crab, lobster) for supplements. Synthetic (non-shellfish) versions are available for allergic individuals [1].
5 Lab interpreter
No routine monitoring
Your level:
Enter a value above
⚕ For healthcare professionals. Does not replace clinical judgment.
6 Quick facts
CategoryOther
Safety levelGenerally Safe
EvidenceModerate
RDATypical 1,500 mg
Upper limit (UL)No UL
Scientific nameGlucosamine sulfate / HCl
Chemical classAmino monosaccharide (2-amino-2-deoxy-D-glucose) [1]
Biological rolePrecursor to glycosaminoglycans (cartilage matrix) [1]
FormsGlucosamine sulfate vs glucosamine HCl (NOT interchangeable) [3]
GAIT trial resultGlucosamine HCl: NO benefit over placebo for knee OA [2]
European trialsGlucosamine sulfate (Rotta): positive for symptom and structure [3]
Typical dose1,500 mg/day glucosamine sulfate [3]
7 Dosage by population
Adults Moderate
See product label
Elderly Moderate
See product label
Consider reduced renal/hepatic clearance. Start at lower end of range.
Pediatric Moderate
See guidance
No pediatric data. Not recommended for children (OA is an adult condition) [1].
Athletes Limited
Standard dose
Obesity Limited
Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
Renal Limited
Consult specialist
Dose adjustment may be needed in renal impairment.
Vegan Moderate
Standard dose
1,500 mg/day crystalline glucosamine SULFATE (not HCl) is the evidence-based dose. Once daily dosing. Response takes 4–8 weeks. The salt form matters: glucosamine sulfate and glucosamine HCl are NOT interchangeable in evidence [2] [3]. Derived from shellfish shells — allergic individuals should use synthetic (non-shellfish) versions [1].
8 Form comparison
| Form | Bioavailability | Vegan | Cost/day |
|---|---|---|---|
| ['Crystalline glucosamine sulfate (Rotta/Rottapharm)', 'preferred', 'Pharmaceutical-grade. The ONLY form with consistent positive trial data (GUIDE, GAIT subgroup). 1,500 mg once daily [3].'] | Standard | Check label | |
| ['Glucosamine HCl', 'common', 'Higher glucosamine content per mg (83% vs 65% in sulfate). BUT this is the form that FAILED in the GAIT trial. Less evidence [2].'] | Standard | Check label | |
| ['Glucosamine + chondroitin combination', 'common', 'GAIT showed the combination was effective in a subgroup with moderate-severe pain (p=0.002), though the primary endpoint was negative [2].'] | Standard | Check label | |
| ['N-Acetyl glucosamine', '', 'Different compound. Less studied for OA. Some GI/immune research [1].'] | Standard | Check label |
9 Clinical evidence
Strong evidence
GAIT trial (n=1,583): glucosamine HCl 1,500 mg/day was NOT superior to placebo for the primary endpoint (knee OA pain) [2]. This is the definitive negative result for the HCl form. The combination of glucosamine + chondroitin DID show benefit in the moderate-severe pain subgroup (p=0.002) [2]. HIGH
Moderate evidence
Crystalline glucosamine sulfate (Rotta): the GUIDE trial and other European RCTs showed symptom reduction comparable to celecoxib and structural preservation (joint space narrowing reduction) over 3 years [3]. The discrepancy with GAIT is attributed to the different salt form. OARSI and ESCEO guidelines conditionally recommend glucosamine sulfate for knee OA [3]. Chondroitin sulfate 800 mg/day: some evidence for pain reduction and structural benefit [1]. MODERATE
Insufficient evidence
10 Safety
🚩 Red flags — when to stop and refer
● Patient on warfarin + glucosamine — monitor INR [1]
● Patient using glucosamine HCl instead of sulfate — explain the evidence difference [2] [3]
Pregnancy
Limited safety data. Generally considered safe as it is a natural body constituent, but supplementation studies in pregnancy are absent. Consult physician [1].
Pediatric
No pediatric data. Not recommended for children (OA is an adult condition) [1].
11 Toxicity and overdose
12 Drug interactions
13 Supplement interactions
Best combined with
Chondroitin sulfate · 800–1,200 mg/day
GAIT subgroup showed benefit. Common combination. Both are GAG precursors [2].
GAIT subgroup showed benefit. Common combination. Both are GAG precursors [2].
Collagen Peptides · 5–10 g/day
Complementary cartilage support — glucosamine (GAGs) + collagen (structural protein) [1].
Complementary cartilage support — glucosamine (GAGs) + collagen (structural protein) [1].
Omega-3 fatty acids · 1–2 g/day EPA+DHA
Anti-inflammatory (EPA) + structural support (glucosamine) [1].
Anti-inflammatory (EPA) + structural support (glucosamine) [1].
14 Laboratory monitoring
No routine monitoring Primary
Target: N/A · N/A [1].
Clinical pain assessment and functional outcomes [3].
INR (if on warfarin) Secondary
Target: Therapeutic range · 1–2 weeks after starting [1].
Joint space width (X-ray) Secondary
Target: Reduced narrowing over time · Baseline and annually for structural assessment [3].
15 Deficiency and prevalence
Risk factors
• Not applicable — not an essential nutrient [1]
16 Frequently asked questions
Why did GAIT fail but European trials succeed? ▼
Does glucosamine actually rebuild cartilage? ▼
The European 3-year trials with glucosamine sulfate showed reduced joint space narrowing on X-ray, suggesting structural preservation [3]. This does not mean cartilage is 'rebuilt' — rather, degradation may be slowed. The effect is modest.
Should I take glucosamine with chondroitin? ▼
Is shellfish allergy a concern? ▼
Glucosamine from shellfish shells is purified protein-free. Most allergists consider it safe for shellfish-allergic individuals (the allergy is to muscle protein, not chitin) [1]. Synthetic versions exist for those who prefer to avoid shellfish entirely.
17 Regulatory status
United States (FDA): Dietary supplement. No approved health claims [1].
European Union: Crystalline glucosamine sulfate is a prescription drug in several EU countries (Italy, Spain, Portugal) [3].
ESCEO guidelines: Conditionally recommend pharmaceutical-grade glucosamine sulfate for knee OA (Step 1 treatment) [3].
South Korea: Available as dietary supplement and pharmaceutical.
18 References
[1]National Institutes of Health, NCCIH. Glucosamine and Chondroitin. Updated 2024. www.nccih.nih.gov REVIEW
[2]Clegg DO, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354(8):795-808. doi:10.1056/NEJMoa052771 REVIEW
[3]Reginster JY, et al. Pharmaceutical-grade glucosamine sulfate for osteoarthritis. Aging Clin Exp Res. 2020;32(4):375-382. doi:10.1007/s40520-019-01399-w REVIEW
19 Related articles
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
📰 Article placeholder — auto-populated via news.gmj.ge
Auto-updated from GMJ Newsroom. Articles tagged "Glucosamine" appear here.
20 Cite this page
Vancouver
Pkhakadze G. Glucosamine — safety profile [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 May 30]. Available from: https://supplement.ge/ingredients/glucosamine/
APA 7th
Pkhakadze, G. (2026). Glucosamine — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/glucosamine/
CC BY 4.0
🛡 SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
GP
Reviewed by Prof. G. Pkhakadze, MD, MPH, PhD
Editor-in-Chief, Georgian Medical Journal · Chair, PHIG
Last reviewed: May 2026 · Next: November 2026
This entry is provided for educational and public health purposes under CC BY 4.0. Consult your healthcare provider before starting any supplement. For corrections: info@accreditation.ge.
Publisher: PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Publisher: PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD